STOCK TITAN

Dexcom to Present at 41st Annual J.P. Morgan Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

DexCom, Inc. (NASDAQ:DXCM) announced that CEO Kevin Sayer will present at the 41st annual J.P. Morgan Healthcare Conference on January 9, 2023, starting at 2:15 PM EST. The presentation will be webcast live and made available for later viewing on the Dexcom Investor Relations website.

DexCom focuses on diabetes management through its innovative continuous glucose monitoring (CGM) systems, serving users globally from its headquarters in San Diego, California.

Positive
  • None.
Negative
  • None.

SAN DIEGO--(BUSINESS WIRE)-- DexCom, Inc. (NASDAQ:DXCM) today announced that Kevin Sayer, Chairman, President and Chief Executive Officer, will present an update on the company at the 41st annual J.P. Morgan Healthcare Conference on January 9, 2023.

The live presentation is scheduled to begin at approximately 2:15 PM EST and will be concurrently webcast.

Links to the webcast will be available on the Dexcom Investor Relations website at investors.dexcom.com and will be archived there for future reference.

About DexCom, Inc.

DexCom, Inc. empowers people to take real-time control of diabetes through innovative continuous glucose monitoring (CGM) systems. Headquartered in San Diego, California, and with operations across Europe and select parts of Asia/Oceania, Dexcom has emerged as a leader of diabetes care technology. By listening to the needs of users, caregivers, and providers, Dexcom simplifies and improves diabetes management around the world. For more information about Dexcom CGM, visit www.dexcom.com.

DexCom, Inc.

Sean Christensen

Vice President – Finance and Investor Relations

investor-relations@dexcom.com

(858) 200-0200

Source: DexCom, Inc.

FAQ

When is DexCom's presentation at the J.P. Morgan Healthcare Conference?

DexCom's presentation is scheduled for January 9, 2023, at 2:15 PM EST.

Who will be presenting for DexCom at the conference?

Kevin Sayer, the Chairman, President, and CEO of DexCom, will present.

Where can I watch DexCom's presentation?

The presentation will be available via a live webcast on the Dexcom Investor Relations website.

What is the purpose of DexCom's participation in the J.P. Morgan Healthcare Conference?

DexCom aims to provide updates on their business and innovations in diabetes care.

What does DexCom specialize in?

DexCom specializes in continuous glucose monitoring (CGM) systems for diabetes management.

DexCom, Inc.

NASDAQ:DXCM

DXCM Rankings

DXCM Latest News

DXCM Stock Data

30.65B
389.06M
0.32%
97.12%
2.33%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
SAN DIEGO